Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Change in Acquisitions & Divestments (2020 - 2025)

BridgeBio Pharma (BBIO) has disclosed Change in Acquisitions & Divestments for 6 consecutive years, with $11.0 million as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments rose 134.62% to $11.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.0 million through Dec 2025, down 82.6% year-over-year, with the annual reading at $11.0 million for FY2025, 82.6% down from the prior year.
  • Change in Acquisitions & Divestments hit $11.0 million in Q4 2025 for BridgeBio Pharma, up from -$31.8 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $443.1 million in Q3 2022 to a low of -$31.8 million in Q4 2024.
  • Historically, Change in Acquisitions & Divestments has averaged $67.8 million across 5 years, with a median of $31.8 million in 2024.
  • Biggest five-year swings in Change in Acquisitions & Divestments: plummeted 97.83% in 2022 and later skyrocketed 1515.67% in 2023.
  • Year by year, Change in Acquisitions & Divestments stood at $75.0 million in 2021, then crashed by 64.17% to $26.9 million in 2022, then tumbled by 42.38% to $15.5 million in 2023, then plummeted by 305.21% to -$31.8 million in 2024, then skyrocketed by 134.62% to $11.0 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for BBIO at $11.0 million in Q4 2025, -$31.8 million in Q4 2024, and $31.8 million in Q3 2024.